![Emma Reeve](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Emma Reeve
Directeur/Membre du Conseil chez
PTC THERAPEUTICS, INC.
Fortune : 787 684 $ au 31/05/2026
Profil
Emma Reeve currently serves as Independent Director at PTC Therapeutics, Inc. since 2018, Director at Ribon Therapeutics, Inc. since 2020, Independent Director at Cardurion Pharmaceuticals, Inc. since 2023, Director at Aadi Subsidiary, Inc. since 2021, Independent Director at Whitehawk Therapeutics, Inc. since 2021, Associate at The Institute of Chartered Accountants in England & Wales, and Trustee at Tufts Medical Center, Inc. Former roles include Chairman at Editas Medicine, Inc. from 2023 to 2024, Senior Director-Research Operations at Merck Research Laboratories Massachusetts LLC from 2004 to 2006, Director at Novitas Loans Ltd., Assistant Controller at Bristol Myers Squibb Co. from 1994 to 2002, Chief Financial Officer & Vice President at PAREXEL International Corp.
in 2017, Chief Financial Officer at Inotek Pharmaceuticals Corp.
from 2006 to 2007, Head-Finance & Administration at Novartis Pharma Schweiz AG from 2012 to 2014, Chief Financial Officer at Aton Pharma, Inc. from 2002 to 2004, Chief Financial Officer, Treasurer & Senior VP at Constellation Pharmaceuticals, Inc. from 2018 to 2021, and Head-Business Planning & Analysis at Novartis Vaccines & Diagnostics SAS from 2008 to 2012.
Education includes undergraduate studies at Imperial College London.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/04/2026 | 10 666 ( 0,01% ) | 787 684 $ | 31/05/2026 | |
| 17/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Emma Reeve
| Sociétés | Poste | Début |
|---|---|---|
| PTC THERAPEUTICS, INC. | Directeur/Membre du Conseil | 18/12/2018 |
| WHITEHAWK THERAPEUTICS, INC. | Directeur/Membre du Conseil | 08/09/2021 |
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services Offers accountancy qualifications and world class business resources | Corporate Officer/Principal | - |
Aadi Subsidiary, Inc.
 Aadi Subsidiary, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Directeur/Membre du Conseil | 01/01/2021 |
Tufts Medical Center, Inc.
 Tufts Medical Center, Inc. Hospital/Nursing ManagementHealth Services Offers academic medicine and research services | Directeur/Membre du Conseil | - |
Ribon Therapeutics, Inc.
 Ribon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops cacner therapies | Directeur/Membre du Conseil | 09/11/2020 |
Cardurion Pharmaceuticals, Inc.
 Cardurion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of heart failure and cardiovascular diseases | Directeur/Membre du Conseil | 04/10/2023 |
Anciens postes connus de Emma Reeve
| Sociétés | Poste | Fin |
|---|---|---|
| EDITAS MEDICINE, INC. | Président | 31/12/2024 |
| CONSTELLATION PHARMACEUTICALS, INC. | Directeur Financier/CFO | 15/07/2021 |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Emma Reeve
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Engages in the development, discovery and commercialization of therapies for glaucoma and other diseases of the eye | Health Technology |
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services Offers accountancy qualifications and world class business resources | Commercial Services |
Novartis Pharma Schweiz AG
 Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Researches and develops vaccines for viral diseases | Commercial Services |
Aton Pharma, Inc.
 Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical therapeutics for cancer and other diseases | Health Technology |
Tufts Medical Center, Inc.
Tufts Medical Center, Inc. Hospital/Nursing ManagementHealth Services Offers academic medicine and research services | Health Services |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs targeting regulators of epigenetic function | Health Technology |
Novartis Vaccines & Diagnostics SAS | |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Ribon Therapeutics, Inc.
Ribon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops cacner therapies | Health Technology |
Cardurion Pharmaceuticals, Inc.
Cardurion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of heart failure and cardiovascular diseases | Health Technology |
Aadi Subsidiary, Inc.
Aadi Subsidiary, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Novitas Loans Ltd.
 Novitas Loans Ltd. Finance/Rental/LeasingFinance Provides loans and legal services | Finance |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
